Adcentrx Therapeutics
Founded 2021 · 20 employees on LinkedIn · 7 known investors
Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.
Founders & leadership
HL
Hui LiinPresident & CEO
Investors · 7
Eight Roads VenturesMumbai · $5M – $30M
F-Prime CapitalCambridge · $3M – $10M
Quan CapitalShanghai
Delta CapitalreportedSantana De Parnaiba
Also in the syndicate · 3
ABio-XPartners InvestmentTrinity Innovation Fund
Funding
SEC filings, press & company announcements$38M disclosed across 1 of 2 rounds · 2023
- Undisclosed amountSeries A+Dec 2023
Eight Roads (lead), Partners Investment, Quan Capital
Source ↗ - $38MSeries A+Apr 2023 · 2 sources
Eight Roads Ventures (lead), ABio-X, Delta Capital, F-Prime Capital, Trinity Innovation Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
Addex Therapeutics18 shared keywordsAddex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.
Bioworld17 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Adcentrx Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adcentrx Therapeutics do?
- Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.
- Who are Adcentrx Therapeutics's investors?
- Adcentrx Therapeutics's investors include Eight Roads Ventures, F-Prime Capital, Quan Capital, Delta Capital.
- How much funding has Adcentrx Therapeutics raised?
- Adcentrx Therapeutics has disclosed $38M raised across 1 of its 2 known rounds.